Cargando…

Cost-effectiveness strategies in OSAS management: a short review

Obstructive sleep apnoea (OSAS) is an underdiagnosed chronic disease with a high prevalence in adults. It is becoming a significant social problem, since it is associated with a worsening in quality of life and increase in mortality. The cost-effectiveness ratio of diagnostic and therapeutic managem...

Descripción completa

Detalles Bibliográficos
Autores principales: Toraldo, D.M., Passali, D., Sanna, A., De Nuccio, F., Conte, L., De Benedetto, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore SRL 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782420/
https://www.ncbi.nlm.nih.gov/pubmed/28663598
http://dx.doi.org/10.14639/0392-100X-1520
_version_ 1783295189325971456
author Toraldo, D.M.
Passali, D.
Sanna, A.
De Nuccio, F.
Conte, L.
De Benedetto, M.
author_facet Toraldo, D.M.
Passali, D.
Sanna, A.
De Nuccio, F.
Conte, L.
De Benedetto, M.
author_sort Toraldo, D.M.
collection PubMed
description Obstructive sleep apnoea (OSAS) is an underdiagnosed chronic disease with a high prevalence in adults. It is becoming a significant social problem, since it is associated with a worsening in quality of life and increase in mortality. The cost-effectiveness ratio of diagnostic and therapeutic management of OSAS is a strategic issue to counteract the expected increasing demand of objective testing. OSAS patients with any clinical evidence of comorbidities must be studied using simplified and less expensive systems such as Home Sleep Testing (HST). On the other hand, Sleep Laboratory Polysomnography (PSG) is the gold standard to manage OSAS patients with comorbidities. It should be pointed out that the use of HST can lead to incorrect diagnosis in poorly selected OSAS subjects. This short review discusses various topics for the proper diagnosis and treatment of OSAS in view of epidemiological factors and results in terms of costs and social benefit of the disease. Whatever the strategy chosen and/or the organisational model adopted for managing OSAS, it cannot and should not take into account only cost-effectiveness. Long-term prospective studies evaluating cost-effectiveness ratios and outcomes of OSAS treatment of hospital management models versus home care models are needed.
format Online
Article
Text
id pubmed-5782420
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Pacini Editore SRL
record_format MEDLINE/PubMed
spelling pubmed-57824202018-01-31 Cost-effectiveness strategies in OSAS management: a short review Toraldo, D.M. Passali, D. Sanna, A. De Nuccio, F. Conte, L. De Benedetto, M. Acta Otorhinolaryngol Ital Review Obstructive sleep apnoea (OSAS) is an underdiagnosed chronic disease with a high prevalence in adults. It is becoming a significant social problem, since it is associated with a worsening in quality of life and increase in mortality. The cost-effectiveness ratio of diagnostic and therapeutic management of OSAS is a strategic issue to counteract the expected increasing demand of objective testing. OSAS patients with any clinical evidence of comorbidities must be studied using simplified and less expensive systems such as Home Sleep Testing (HST). On the other hand, Sleep Laboratory Polysomnography (PSG) is the gold standard to manage OSAS patients with comorbidities. It should be pointed out that the use of HST can lead to incorrect diagnosis in poorly selected OSAS subjects. This short review discusses various topics for the proper diagnosis and treatment of OSAS in view of epidemiological factors and results in terms of costs and social benefit of the disease. Whatever the strategy chosen and/or the organisational model adopted for managing OSAS, it cannot and should not take into account only cost-effectiveness. Long-term prospective studies evaluating cost-effectiveness ratios and outcomes of OSAS treatment of hospital management models versus home care models are needed. Pacini Editore SRL 2017-12 /pmc/articles/PMC5782420/ /pubmed/28663598 http://dx.doi.org/10.14639/0392-100X-1520 Text en © Copyright by Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale, Rome, Italy http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way. For details, please refer to http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Review
Toraldo, D.M.
Passali, D.
Sanna, A.
De Nuccio, F.
Conte, L.
De Benedetto, M.
Cost-effectiveness strategies in OSAS management: a short review
title Cost-effectiveness strategies in OSAS management: a short review
title_full Cost-effectiveness strategies in OSAS management: a short review
title_fullStr Cost-effectiveness strategies in OSAS management: a short review
title_full_unstemmed Cost-effectiveness strategies in OSAS management: a short review
title_short Cost-effectiveness strategies in OSAS management: a short review
title_sort cost-effectiveness strategies in osas management: a short review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782420/
https://www.ncbi.nlm.nih.gov/pubmed/28663598
http://dx.doi.org/10.14639/0392-100X-1520
work_keys_str_mv AT toraldodm costeffectivenessstrategiesinosasmanagementashortreview
AT passalid costeffectivenessstrategiesinosasmanagementashortreview
AT sannaa costeffectivenessstrategiesinosasmanagementashortreview
AT denucciof costeffectivenessstrategiesinosasmanagementashortreview
AT contel costeffectivenessstrategiesinosasmanagementashortreview
AT debenedettom costeffectivenessstrategiesinosasmanagementashortreview